The institutional development award states pediatric clinical trials network

Building research capacity among the rural and medically underserved

Jessica Snowden, Paul Darden, Paul Palumbo, Phil Saul, Jeannette Lee

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Purpose of review The institutional development award (IDeA) program was created to increase the competitiveness of investigators in states with historically low success rates for National Institutes of Health (NIH) research funding applications. IDeA states have high numbers of rural and medically underserved residents with disproportionately high rates of infant mortality, obesity, and poverty. This program supports the development and expansion of research infrastructure and research activities in these states. The IDeA States Pediatric Clinical Trials Network (ISPCTN) is part of the environmental influences on child health outcomes program. Its purpose is to build research capacity within IDeA states and provide opportunities for children in IDeA states to participate in clinical trials. This review describes the current and future activities of the network. Recent findings In its initial year, the ISPCTN created an online series on clinical trials, initiated participation in a study conducted by the pediatric trials network, and proposed two novel clinical trials for obese children. Capacity building and clinical trial implementation will continue in future years. Summary The ISPCTN is uniquely poised to establish and support new pediatric clinical research programs in underserved populations, producing both short and long-term gains in the understanding of child health.

Original languageEnglish (US)
Pages (from-to)297-302
Number of pages6
JournalCurrent Opinion in Pediatrics
Volume30
Issue number2
DOIs
StatePublished - Apr 1 2018

Fingerprint

Capacity Building
Clinical Trials
Pediatrics
Research
Pediatric Obesity
National Institutes of Health (U.S.)
Infant Mortality
Vulnerable Populations
Poverty
Research Personnel

Keywords

  • capacity building and professional development for clinical trial implementation
  • multicenter pediatric clinical trials
  • rural and underserved children

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

The institutional development award states pediatric clinical trials network : Building research capacity among the rural and medically underserved. / Snowden, Jessica; Darden, Paul; Palumbo, Paul; Saul, Phil; Lee, Jeannette.

In: Current Opinion in Pediatrics, Vol. 30, No. 2, 01.04.2018, p. 297-302.

Research output: Contribution to journalReview article

@article{b3004271c440493391e14059492f25ed,
title = "The institutional development award states pediatric clinical trials network: Building research capacity among the rural and medically underserved",
abstract = "Purpose of review The institutional development award (IDeA) program was created to increase the competitiveness of investigators in states with historically low success rates for National Institutes of Health (NIH) research funding applications. IDeA states have high numbers of rural and medically underserved residents with disproportionately high rates of infant mortality, obesity, and poverty. This program supports the development and expansion of research infrastructure and research activities in these states. The IDeA States Pediatric Clinical Trials Network (ISPCTN) is part of the environmental influences on child health outcomes program. Its purpose is to build research capacity within IDeA states and provide opportunities for children in IDeA states to participate in clinical trials. This review describes the current and future activities of the network. Recent findings In its initial year, the ISPCTN created an online series on clinical trials, initiated participation in a study conducted by the pediatric trials network, and proposed two novel clinical trials for obese children. Capacity building and clinical trial implementation will continue in future years. Summary The ISPCTN is uniquely poised to establish and support new pediatric clinical research programs in underserved populations, producing both short and long-term gains in the understanding of child health.",
keywords = "capacity building and professional development for clinical trial implementation, multicenter pediatric clinical trials, rural and underserved children",
author = "Jessica Snowden and Paul Darden and Paul Palumbo and Phil Saul and Jeannette Lee",
year = "2018",
month = "4",
day = "1",
doi = "10.1097/MOP.0000000000000597",
language = "English (US)",
volume = "30",
pages = "297--302",
journal = "Current Opinion in Pediatrics",
issn = "1040-8703",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - The institutional development award states pediatric clinical trials network

T2 - Building research capacity among the rural and medically underserved

AU - Snowden, Jessica

AU - Darden, Paul

AU - Palumbo, Paul

AU - Saul, Phil

AU - Lee, Jeannette

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Purpose of review The institutional development award (IDeA) program was created to increase the competitiveness of investigators in states with historically low success rates for National Institutes of Health (NIH) research funding applications. IDeA states have high numbers of rural and medically underserved residents with disproportionately high rates of infant mortality, obesity, and poverty. This program supports the development and expansion of research infrastructure and research activities in these states. The IDeA States Pediatric Clinical Trials Network (ISPCTN) is part of the environmental influences on child health outcomes program. Its purpose is to build research capacity within IDeA states and provide opportunities for children in IDeA states to participate in clinical trials. This review describes the current and future activities of the network. Recent findings In its initial year, the ISPCTN created an online series on clinical trials, initiated participation in a study conducted by the pediatric trials network, and proposed two novel clinical trials for obese children. Capacity building and clinical trial implementation will continue in future years. Summary The ISPCTN is uniquely poised to establish and support new pediatric clinical research programs in underserved populations, producing both short and long-term gains in the understanding of child health.

AB - Purpose of review The institutional development award (IDeA) program was created to increase the competitiveness of investigators in states with historically low success rates for National Institutes of Health (NIH) research funding applications. IDeA states have high numbers of rural and medically underserved residents with disproportionately high rates of infant mortality, obesity, and poverty. This program supports the development and expansion of research infrastructure and research activities in these states. The IDeA States Pediatric Clinical Trials Network (ISPCTN) is part of the environmental influences on child health outcomes program. Its purpose is to build research capacity within IDeA states and provide opportunities for children in IDeA states to participate in clinical trials. This review describes the current and future activities of the network. Recent findings In its initial year, the ISPCTN created an online series on clinical trials, initiated participation in a study conducted by the pediatric trials network, and proposed two novel clinical trials for obese children. Capacity building and clinical trial implementation will continue in future years. Summary The ISPCTN is uniquely poised to establish and support new pediatric clinical research programs in underserved populations, producing both short and long-term gains in the understanding of child health.

KW - capacity building and professional development for clinical trial implementation

KW - multicenter pediatric clinical trials

KW - rural and underserved children

UR - http://www.scopus.com/inward/record.url?scp=85044227560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044227560&partnerID=8YFLogxK

U2 - 10.1097/MOP.0000000000000597

DO - 10.1097/MOP.0000000000000597

M3 - Review article

VL - 30

SP - 297

EP - 302

JO - Current Opinion in Pediatrics

JF - Current Opinion in Pediatrics

SN - 1040-8703

IS - 2

ER -